Anzeige
Erschienen in:
19.04.2018 | Commentary
A novel approach to improving ambulatory outpatient management of low risk febrile neutropenia: an Enhanced Supportive Care (ESC) clinic
Erschienen in: Supportive Care in Cancer | Ausgabe 9/2018
Einloggen, um Zugang zu erhaltenAbstract
Purpose
Outpatient management of low risk febrile neutropenia patients (LRFN) identified by the MASCC score is a safe and effective strategy. Early supportive care has been shown to improve outcomes in patients with care. We developed an innovative ambulatory outpatient “enhanced supportive care” (ESC) clinic combining emergency oncology and supportive care through which we incorporated the management of patients with LRFN.
Methods
An ESC clinic was started in January 2017 at a tertiary cancer hospital in the North West of England. An integral part of the clinic was an ambulatory pathway for patients presenting with LRFN. Patients with a MASCC score ≥ 21 and an Early Warning Score ≤ 3 were potentially eligible for the pathway. Suitable patients were managed with oral amoxicillin/clavulanic acid (500/125 mg TDS) and ciprofloxacin (500 mg BD) or moxifloxacin 400 mg OD if penicillin allergic. All patients had one dose of intravenous meropenem on arrival.
Results
In its first year, 68 patients with LRFN were managed through the clinic. Table 1 shows the demographic data of the patients. Six (8.8%) patients had a 7-day readmission. There were no serious complications in the cohort.
Conclusion
The ESC clinic maybe an effective method for delivering outpatient ambulatory management of patients with LRFN.